Table 1 Patients’ demographics
From: Regional differences in the reduction in cerebral FDG uptake induced by the ketogenic diet
Pt No. | Age | Gender | Weight | Height | T1DM/T2DM | Oral hypoglycaemic | Insulin | Dietary adherence | Fasting period | Serum ketones | In ketosis? | Urinary ketones | Blood glucose | Heparin (50U/kg, max 5000U) | Injected activity (MBq) | Uptake period (min) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 66 | M | 115.8 | 186 | – | – | – | Yes | 20.1 | 0.6 | Yes | Not done | 5.3 | No | 314 | 68 |
3 | 62 | M | 115.1 | 188 | – | – | – | Yes | 23.5 | 0.6 | Yes | Negative | 5.2 | No | 331 | 95 |
4 | 61 | F | 102 | 157 | T2DM | Metformin | No | Yes | 19.9 | 0.6 | Yes | Negative | 5.9 | No | 310 | 76 |
6 | 78 | M | 98.3 | 172 | – | – | – | Yes | 18.2 | 0.9 | Yes | 3.9 | 5.1 | No | 299 | 60 |
7 | 86 | M | 70.4 | 171 | – | – | – | Yes | 18.9 | 1.2 | Yes | 1.5 | 4.4 | No | 289 | 78 |
9 | 53 | F | 64.4 | 164 | – | – | – | No | 19.9 | 0.7 | Yes | Negative | 4.6 | No | 266 | 58 |
10 | 66 | F | 76 | 162 | T2DM | Metformin, Gliclazide | No | Yes | 20.7 | 0.4 | No | Negative | 9.3 | 3800 | 282 | 64 |
12 | 51 | F | 80.6 | 162 | – | – | – | Yes | 19.3 | 1.1 | Yes | 3.9 | 4.3 | 4000 | 313 | 66 |
13 | 48 | M | 71.6 | 167 | – | – | – | Yes | 18.8 | 0.4 | No | Negative | 5.5 | 3600 | 307 | 70 |
14 | 76 | M | 112.7 | 176 | – | – | – | Yes | 19.5 | 1.3 | Yes | 3.9 | 4.4 | 5000 | 323 | 60 |
15 | 36 | F | 79.8 | 168 | – | – | – | Yes | 20.9 | 0.8 | Yes | 1.5 | 5.4 | 4000 | 300 | 60 |
16 | 74 | M | 82.9 | 176 | – | – | – | Yes | 19.6 | 0.7 | Yes | 1.5 | 5.6 | No | 317 | 71 |
17 | 60 | M | 84 | 179 | – | – | – | Yes | 21.3 | 1.1 | Yes | 3.9 | 4.3 | No | 319 | 72 |
18 | 60 | F | 78.1 | 157 | T2DM | Metformin, Dapagliflozin | 25 U mane | Yes | 19.0 | 1.7 | Yes | 3.9 | 5.3 | 3900 | 307 | 71 |
19 | 38 | M | 115.2 | 176 | – | – | – | Yes | 20.8 | 0.6 | Yes | 3.9 | 4.4 | 5000 | 301 | 70 |
22 | 49 | M | 107.7 | 184 | – | – | – | Yes | 25.5 | 0.8 | Yes | 1.5 | 5.7 | 5000 | 338 | 63 |
23 | 59 | M | 117 | 176 | – | – | – | Yes | 19.4 | 0.3 | No | Negative | 5.6 | 5000 | 265 | 57 |
24 | 47 | M | 73.5 | 174 | – | – | – | Yes | 18.2 | 0.9 | Yes | 1.5 | 3.6 | No | 306 | 78 |
25 | 32 | M | 129.3 | 167 | – | – | – | Yes | 19.8 | 0.3 | No | Negative | 5.3 | No | 313 | 73 |
26 | 55 | M | 125.4 | 171 | T2DM | – | Lantus, Novorapid | Yes | 19.0 | 0.2 | No | Negative | 7.7 | 5000 | 317 | 68 |
27 | 59 | M | 73 | 173 | – | – | – | Yes | 19.9 | 0.8 | Yes | 1.5 | 4.4 | 3650 | 301 | 61 |
28 | 46 | M | 114 | 176 | T2DM | Metformin, Gliclazide, Sitagliptin | No | No | 19.1 | 0.7 | Yes | Not done | 7.5 | 5000 | 282 | 66 |
29 | 59 | M | 85.5 | 175 | – | – | – | Yes | 18.8 | 0.7 | Yes | Not done | 4.1 | No | 322 | 66 |
30 | 62 | F | 69 | 157 | – | – | – | Yes | 19.3 | 2.5 | Yes | > 15.6 | 3.9 | No | 307 | 60 |
31 | 40 | M | 88 | 175 | – | – | – | Yes | 20.3 | 0.8 | Yes | 3.9 | 4.6 | 4400 | 309 | 64 |
32 | 40 | M | 71 | 172 | – | – | – | No | 19.3 | 2.1 | Yes | 3.9 | 4.4 | 3500 | 304 | 58 |
33 | 48 | F | 75.5 | 170 | – | – | – | Yes | 19.4 | 0.7 | Yes | Negative | 4.2 | No | 322 | 68 |
34 | 50 | M | 116 | 178 | – | – | – | Yes | 17.0 | 0.8 | Yes | Not done | 4.9 | 5000 | 314 | 60 |
36 | 76 | M | 79.8 | 168 | – | – | – | Yes | 22.5 | 1.3 | Yes | 3.9 | 4.9 | 4000 | 302 | 57 |
37 | 60 | M | 105 | 182 | – | – | – | Yes | 21.2 | 0.5 | Yes | Trace | 4.7 | 5000 | 287 | 60 |
38 | 75 | F | 105.9 | 163 | – | – | – | Yes | 16.7 | 0.3 | No | Negative | 4.8 | No | 225 | 86 |
39 | 67 | M | 99.5 | 175 | T2DM | Metformin, Vildagliptin, Empagliflozin | No | No | 7.0 | 3.8 | Yes | 3.9 | 9.7 | No | 290 | 74 |
40 | 55 | M | 91.3 | 178 | – | – | – | Unknown | 22.0 | 0.8 | Yes | 3.9 | 4.4 | 4500 | 330 | 76 |
41 | 77 | F | 80.3 | 154 | T2DM | Metformin | No | Yes | 20.3 | 0.5 | Yes | Negative | 7.1 | No | 330 | |
42 | 63 | M | 94.5 | 189 | – | – | – | Yes | 24.1 | 0.5 | Yes | Negative | 5.8 | No | 309 | 70 |
43 | 55 | M | 83.2 | 162 | T2DM | Metformin, Empagliflozin | No | Yes | 19.3 | 1.9 | Yes | 3.9 | 8.4 | No | 309 | 62 |
44 | 58 | F | 89.7 | 164 | – | – | – | Yes | 22.1 | 1.8 | Yes | 7.8 | 4.3 | 4650 | 290 | 50 |
45 | 57 | M | 163 | 182 | T2DM | Metformin, Sitagliptin | No | Yes | 20.2 | 0.3 | No | Negative | 11.7 | 5000 | 302 | 108 |
46 | 35 | M | 79.1 | 185 | T1DM | No | Lantus, Novorapid | Yes | 21.6 | 0.3 | No | Negative | 4.1 | 4000 | 307 | 67 |
48 | 45 | M | 107.8 | 180 | – | – | – | Yes | 19.2 | 0.6 | Yes | Trace | 6.1 | 5000 | 310 | 60 |
49 | 33 | M | 95.2 | 172 | – | – | – | Yes | 19.6 | 0.3 | No | Negative | 5.4 | No | 309 | 78 |
50 | 76 | F | 75.1 | 168 | T2DM | No | Novomix | Yes | 18.7 | 1.6 | Yes | Negative | 8.9 | No | 310 | 87 |
51 | 66 | M | 90.4 | 162 | – | – | – | Yes | 19.1 | 0.8 | Yes | Trace | 5.8 | No | 311 | 64 |
53 | 56 | F | 63.6 | 156 | – | – | – | Yes | 19.3 | 1.7 | Yes | Negative | 4.8 | 3250 | 273 | 77 |
58 | 62 | M | 130 | 161 | T2DM | Metformin | Novorapid, Lantus | No | 19.0 | 1.1 | Yes | Trace | 9 | No | 331 | 59 |
60 | 66 | F | 72 | 163 | – | – | – | Yes | 18.8 | 0.3 | No | Negative | 5.9 | No | 276 | 57 |
61 | 47 | M | 75.4 | 174 | – | – | – | Yes | 19.5 | 0.6 | Yes | Negative | 4.9 | 3750 | 309 | 62 |
63 | 82 | M | 75.1 | 161 | – | – | – | Yes | 20.8 | 1.6 | Yes | Not done | 4.3 | No | 300 | 64 |
66 | 59 | M | 98 | 179 | – | – | – | Yes | 17.0 | 0.4 | No | Negative | 5.5 | 4900 | 313 | 86 |
67 | 44 | F | 74.8 | 160 | – | – | – | Yes | N/A | 0.8 | Yes | Trace | 6.2 | 3700 | 309 | 81 |
70 | 64 | M | 94.5 | 170 | T2DM | Metformin | No | Yes | 15.0 | 0.4 | No | Negative | 5.3 | No | 309 | 61 |
72 | 73 | M | 44 | 162 | – | – | – | Yes | 17.7 | 5.4 | Yes | 1.5 | 2.4 | No | 184 | 74 |